Ninlaro 2.3 mg

Ninlaro 2.3 mg is a medicine authorised by Swissmedic under authorisation number 65959. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 February 2017 and the authorisation is valid without a time limit. ATC code L01XG03 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 65959
ATC L01XG03
Synthetic medicines

Authorisation data
Authorisation number	65959
Name	Ninlaro 2.3 mg
Full name	Ninlaro 2.3 mg, Hartkapseln
Authorisation holder	Takeda Pharma AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01XG03
First authorisation	03 February 2017
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Ninlaro 2.3 mg, Hartkapseln	A	03 February 2017
2	Ninlaro 3.0 mg, Hartkapseln	A	03 February 2017
3	Ninlaro 4.0 mg, Hartkapseln	A	03 February 2017

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	3	Kapsel(n)	L01XG03	07.16.1.	A
2	3	Kapsel(n)	L01XG03	07.16.1.	A
3	3	Kapsel(n)	L01XG03	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B

Frequently asked questions

Is Ninlaro 2.3 mg authorised in Switzerland?

Yes. Ninlaro 2.3 mg is authorised by Swissmedic under authorisation number 65959, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ninlaro 2.3 mg have?

Ninlaro 2.3 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ninlaro 2.3 mg?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.